A method of treating NSCLC comprising in some aspects administering OSI-906 and an EGFR inhibitor to a patient having NSCLC having an activating EGFR mutation, as disclosed herein.
申请公布号
WO2012129145(A1)
申请公布日期
2012.09.27
申请号
WO2012US29598
申请日期
2012.03.19
申请人
OSI PHARMACEUTICALS, LLC;THOMSON, STUART;BROWN, ERIC, N.;CHAU, ANDREW;FRANKLIN, MARYLAND;IWATA, KENNETH, K.
发明人
THOMSON, STUART;BROWN, ERIC, N.;CHAU, ANDREW;FRANKLIN, MARYLAND;IWATA, KENNETH, K.
